While Tesla Motors, Inc. (TSLA) continues to make headlines with the rapid growth and development of its new battery grid business – with recent estimates forecasting $45 million in sales during the fourth quarter of this year – the resulting rise in demand for reliable battery systems is providing a platform for strong financial growth across the stored energy industry. Galenfeha, Inc. (OTC: GLFH), through the commercialization of its innovative lithium iron phosphate (LiFePO4) chemistry and patent-pending onboard battery management system, is capitalizing on this opportunity, expanding upon its current customer base through potentially lucrative distribution channels.

Last month, Galenfeha utilized this strategy to great success by partnering with ABB Group, a global leader in power and automation technologies. Through this agreement, the company expects to significantly expand its existing customer base while promoting improved financial returns in the months to come.

“It is a privilege to be represented in ABB’s product offerings,” Lucien Marioneaux, Jr., president and chief executive officer of Galenfeha, stated in a news release. “This affiliation will enable Galenfeha to significantly broaden its customer base locally, nationally, even internationally, and we couldn’t be more pleased with this development.”

Traditional lead-acid batteries have a collection of disadvantages that limit their effectiveness in most stored power applications – including inefficient charging and discharging, the production of gas byproducts during charging and heavy, bulky construction. Galenfeha’s proprietary LiFePO4 chemistry and onboard battery management system addresses each of these disadvantages, providing a light-weight, environmentally-friendly alternative with excellent thermal stability and an improved lifespan.

For solar power generation, these benefits can translate into significant cost savings for the company’s customers. In addition to eliminating the need for a solar regulator, Galenfeha’s battery management system increases charging efficiency, allowing for the use of smaller, more cost-effective solar panels.

In the first quarter of 2015, Galenfeha provided a preview of its tremendous market potential, recording a 173 percent quarter-over-quarter increase in total revenue on the way to a gross profit of approximately $122,000. For prospective shareholders, these results could foreshadow an opportunity for the company to promote sustainable returns moving forward. Look for Galenfeha to continue leaning on its groundbreaking product portfolio in order to build upon its recent progress toward expanding its customer base in the years to come.
Take a closer look at the company by visiting www.galenfeha.com.

Let us hear your thoughts: Galenfeha, Inc. Message Board

Earlier today, Arotech reported a $6.7 task order from the Space and Naval Warfare Center (SPAWAR) Atlantic. The contract came through its North American Power System Division, which includes UEC Electronics.

The contract awarded is for the manufacture and integration of 12 Communication Emitter Sensing and Attacking System (CESAS) II Platform Integration Kits (PIK). The CESAS is the Marine Corps’ only high-power, ground-mobile electronic attack (EA) asset. The CESAS provides Commanders with the capability to detect, deny, and disrupt the communications of their enemy.

“UEC Electronics has been supporting the SPAWAR Intelligence group for more than 10 years and is pleased with the most recent contract award,” said Mark Matthews, CEO of UEC Electronics. “The DoD is focused on cost savings. Our automated manufacturing processes, coupled with our history of quality products and on-time delivery, make us an ideal provider for this type of mission critical system.”

Arotech received this award following the successful completion of a prototype test of the CESAS II PIK, which performed exceptionally well during U.S. Government-led performance and environmental testing.

Arotech expects to complete this production contract in the next 12 months. The government has an option which, if exercised, will result in a second year of support for the program.

Steven Esses, President and CEO of Arotech, commented, “The award of this contract is a testament to our team and performance of our product. We are excited about the initial opportunity and are optimistic that this award could lead to the procurement of additional units in the future.”

For more information, visit www.arotech.com

ENGlobal Corp., a specialty engineering services firm that focuses on oil and gas automation solutions, subsea control systems, and engineering and construction projects, was recently highlighted in a Seeking Alpha article, touching on how the company’s management team has turned the company back to profitability and staying profitable in spite of the current energy slump. The article indicates that the company is an undervalued micro-cap, given that the energy infrastructure industry is now in high demand, and that ENGlobal represents a high potential for a buyout.

In particular, the article (by Nicholas Bodnar) suggests that ENGlobal “is undervalued on a few different metrics”, giving investors “a great chance to get in at depressed levels”, with a significant long-term return potential. It points out the efforts made to minimize risk, and how ENGlobal management has been investing more into the automation side of the business, seen as a way of reducing the risks associated with profitability. It also points to the company’s prudent balance sheet, calling the chance of insolvency “almost non-existent”.

ENGlobal is about automation solutions and EPCM (Engineering, Procurement, Construction Management) projects, serving all levels of the energy industry, as well as pulp-and-paper, alternative energy, and government. The company offers services in engineering and construction, automation engineering/integration/design, and subsea controls and integration. Over the past two decades, they’ve developed a global reputation for designing state-of-the-art plant automation systems. The company’s driving vision is to become the preferred provider of innovative automation integration services and select EPCM projects to clients around the world.

Careful to differentiate themselves from companies where “quality” is more word than action, ENGlobal feels that they stake their reputation on delivering value-added products and services of the highest level, carefully following ISO-9001 guidelines. Establishing clear objectives at the outset of every project, the company emphasizes that it maintains open lines of communication throughout the duration of every project, strengthening working relationships to better understand and meet the client needs.

The Seeking Alpha article concludes that ENGlobal offers long-term investors an “enormous long-run upside”, with “a potential to make at least a 220% return in 3 years”.

For the complete article, go to http://seekingalpha.com/article/3431716-englobal-is-a-great-deep-value-micro-cap-energy-play.

For more information on the company, visit www.ENGlobal.com

Alternet has a history of recognizing and investing in technologies of the future. As technology has progressed, the company has widened its search for investment and partnership opportunities from internet phone service, e-tickets and mobile payments to digital banking and currency.

Alternet has a vision of a world where people have access to well-organized and affordable banking and payment services. After assessing the global market and a multitude of investment ventures, the company sees opportunity in the rise of revolutionary forms of payments and banking as well as real-time big data micro-analytics and automation. Equipped with knowledge of macro technology trends and observing the convergence of mobile technologies and financial services, Alternet has placed itself at the cutting edge of the multi-billion dollar multi-channel electronic payments, financial services and consumer analytics industries.

Alternet is an enterprise accelerator company focused on a number of complementary, fast growth markets, including Internet and mobile commerce, digital currency and cyber-security products and services. The company and its subsidiaries capture and convert high growth opportunities bordering the boom of newly adapted Internet technologies and platforms.

A true business-to-business facilitator in the digital asset and virtual currency ecosystem, Alternet is pursuing and developing multiple strategic initiatives:

• It means to establish a government-regulated digital currency bank with foreign exchange capabilities; to offer micro payment services in unbanked environments around the world; and to offer alternate financial services to the retail industry and other emerging markets.

• It plans to provide financial services based on digital asset solutions, which include foreign exchange services and digital currency clearing, comprising Bitcoin, VEN and other crypto currencies.

• It intends to provide security for digital currencies.

• It is also planning to offer financial services software, multi-channel payment solutions, electronic point of sale modernization, NFC point of sale solutions for the mobile financial industry, payment processing and data analytics tools.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

Medical marijuana continues to act as the narrow end of the wedge for a broader legalization of cannabis and cannabis-derived products nationwide, with parents now demanding medical access across the country to what they see as relatively-safe, life-saving drugs. Such as in the cases like those of two young girls in Pittsburgh (where legislation is currently pending that would allow medical marijuana to be used), ages 12 and 15, reported recently by NBC News. One girl is barely able to move after a nasty series of epileptic seizures and the other was just discharged after a similar episode, consisting of 15 grand mal seizures that occurred within a period of 36 hours.

The mothers of both girls are members of a growing army of parents and national marijuana advocates pushing for legislative reform on the cannabis issue. This efflorescing movement, led by medical access and compassionate care concerns, is being spurred on by the mounting body of empirical evidence emerging from landmark clinical studies which are daily helping to document the benefits of phytocannabinoids, such as CBD (cannabidiol, a non-psychoactive cannabinoid) and THC (the more famous psychoactive cannabinoid), for treating conditions like epilepsy, as well as helping to regulate a wide variety of other problematic conditions, such as chronic pain. In this case, one of the girls is actually enrolled in an ongoing clinical trial, while the other is not. This case shines a bright light on the underlying problem of state legislatures dragging their feet on the issue and offers stark contrast for the recent FDA approval of prescription opioid OxyContin for children as young as 11, who are recovering from extensive trauma or major surgery.

On the other end of the cannabis legalization spectrum from compassionate care and medical access forces we have tax revenues, which are extremely appealing to increasingly strapped state legislatures, and which are looking more and more politically feasible given the growing receptivity to marijuana reform among the general populace. Just recently, ResponsibleOhio, a marijuana reform advocacy group with a $20 million war chest, which is pushing hard for the legalization of at least medical marijuana (MMJ) in Ohio, secured enough signatures to get a ballot initiative on the books for this November. County and local government officials are already starting to buzz about the estimated $554 million in annual tax revenues projected by ResponsibleOhio’s newest report if the state’s legal, regulated cannabis market stabilizes by 2020.

With Washington bringing in $70 million in tax revenues and Colorado pulling down around $40 million during their first years, seven other states are currently poised to pass similar reforms that would at least allow MMJ access for patients. In Nevada, where MMJ was technically legalized back in 2000, dispensaries are just now cropping up after the passage of Senate Bill 374 in 2013, and the subsequent dolling out of operating licenses beginning in late November last year. Clark County, where Las Vegas resides, has been the tip of the spear in many respects, passing its own proactive zoning and land use process regulations for MMJ businesses ahead of schedule. A fact not lost on some analysts, who are projecting a rapid flourishing of the state’s cannabis market. With estimates of around $100 million plus in annual revenues, driven in part by a currently still emerging health tourism-centric regulatory structure, as well as the never-ending influx of people from all over the world who flock to the global entertainment mecca that is Las Vegas every year, Nevada could be one of the fastest growing national markets for cannabis, medical or otherwise.

This seemingly ideal market environment is a major reason why plant biology and cultivation focused biopharma, GrowBLOX Sciences (OTC: GBLX), has targeted Nevada for the rollout of its principal cultivation facility, which will be furnished with the company’s proprietary suite of technologies designed to achieve scalable production of consistently top quality MMJ materials and extracts. With initial production-model units of the company’s GrowBLOX™ controlled-environment solution already shipped to its GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR) facilities, GBLX is fast on its way to demonstrating to the now $3.5 billion U.S. market (2015 estimate according to ArcView), just how far the company has come in terms of designing an efficient lifecycle cultivation solution.

GrowBLOX Sciences is looking to become a major player as the cannabis sector swells to around $10.8 billion over the next four years, deploying its solution – which spans tissue culture propagation of high-value proprietary strains in a controlled environment, through to consistently top quality end product and derived extracts – to eager regions which have passed the requisite reforms. Having secured a $1.75 million funding commitment for the build out of its initial MME (medical marijuana establishment) back in June and having subsequently reported in late July that the company is on track to complete the build of its Nevada Cultivation Labs, GBLX has now reached a major transitional milestone, where the company is focused on branding, production, revenue generation and staffing, instead of R&D, or licensure efforts.

Nevada’s 136 licensed dispensaries, combined with a lack of in-state cultivation, makes this a particularly auspicious move by GBLX, and the company’s state-of-the-art cultivation facility should not only impress sector players by its prowess, it should capture a sizeable share of a state market that is currently estimated as growing by around 341 percent this year alone. Pacific Leaf Ventures ponied up the $1.75 million funding commitment for this initial cultivation lab and has also provided license for IP related to its highly recognizable brand names of cannabis, as well as certain cultivation and extraction techniques. Slated to begin producing sometime in Q4 this year, GLBX’s Nevada Cultivation Labs will not only secure the reputation of the Pacific Leaf brand name and the quality of its cannabis strains through impeccably consistent output (fueling the local market with a scalable supply of products), it will also help cement brand identity and recognition among patients with reciprocal MME cards from neighboring states like Arizona and California.

The incredibly powerful TissueBLOX, GrowBLOX and CureBLOX cultivation architecture developed by GBLX, which allows for scalable production of genetically pure strains of cGMP-certified cannabis, has the potential to transform the cultivation segment of the burgeoning nationwide cannabis space.

Investors are encouraged to learn more about the technology by visiting www.growblox.com

Let us hear your thoughts: GrowBLOX Sciences, Inc. Message Board

Star Mountain Resources, a minerals exploration company focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts, announced it is continually pursuing merger and acquisition opportunities for mines, advanced projects and immature projects that are available at opportunistic costs as a result of the current mining cycle downturn.

“As part of our strategy to strategically position ourselves for the inevitable upturn in the commodity markets, we are presently pursuing the previously announced acquisition of an underground base metal mine located in North America subject to completion of financing,” stated Joseph Marchal, CEO of Star Mountain Resources. “The mine is permitted and in compliance with current Federal and State mining regulations and is on care and maintenance status. We intend to upgrade and modernize certain infrastructure systems, develop additional access to existing mining areas and restart production at this mine within 6 to 9 months.”

Marchal continued, “Based on data provided to us during our due diligence on this proposed acquisition, we believe that the base metal mine opportunity presents to us the possibility of outstanding cash flows in the near term, showing a viable net present value and an attractive internal rate of return. By completing this acquisition and raising the capital needed to complete it, we expect to meet the listing requirements for a national stock exchange. We believe that an up-listing to a national stock exchange will further enhance our efforts to raise additional capital needed to identify and complete the acquisition of other quality properties and projects.”

A significant decline in commodity prices has created an environment for opportunistic quality projects at competitive prices. The management team at Star Mountain Resources is fully committed to accessing the capital markets and seek up-listing to a national securities exchange. Coupled with the mining experience of its leadership team, the company is well positioned to recognize quality acquisition opportunities and to operate those acquisitions profitably.

For more information, visit www.starmountainresources.com

Let us hear your thoughts: Star Mountain Resources Inc. Message Board

Today, On the Move Systems issued a press release to announce that it has a solution to help the nation’s retailers cut delivery times to almost zero with its proposed shared economy courier service.

Amazon has been experimenting with various technologies to slice its delivery times in order to better compete in an ever-crowded field. The company has even considered using drones to get its packages to waiting customers with lightning-fast speed.

One online shopping survey reported 42 percent of customers abandoned potential purchases and went to other retail sites to buy because of delivery time estimates. More than 40 percent of those surveyed said they expect options for two- to three-day delivery, and a third of respondents said they would pay a fee to ensure rapid delivery.

“Customers’ desire for ever-faster delivery has opened a potentially lucrative niche market for someone who can provide flexible, rapid courier services,” said OMVS CEO Robert Wilson. “There are tens of thousands of retailers who ship products to customers and both they and their clients might appreciate a faster, cheaper alternative to FedEx and UPS. With an online, on-demand courier service, we can fill that niche for them and build consistent shareholder value for our investors as well.”

OMVS has been conducting due diligence and market research on starting a shared economy courier service in addition to its on-demand trucking platform, now under development. The company has found strong potential for such a service and is scouting possible startup locations.

For more information on OMVS, please visit www.onthemovesystems.com

Let us hear your thoughts: On the Move Systems Corp. Message Board

Today before the opening bell, Aristocrat Group Corp. announced that Curtis Braly, a music artist sponsored by the company, performed for the largest audience of his career so far recently at the kickoff to his All About the Ride Tour at Houston’s Bayou Music Center.

The event, held earlier this month at one of North America’s top-drawing live-music theaters, was co-sponsored by ASCC’s RWB Ultra-Premium Handcrafted Vodka. RWB Vodka signage was displayed prominently on the venue’s large projection screens, introducing the highly decorated American-made spirit to a huge number of country music fans.

“This was an important night for Curtis’ career, and his loyal and enthusiastic hometown fans came out in force to support him,” said ASCC CEO Robert Federowicz. “It was the perfect way for our company to raise the visibility of our premiere distilled spirit, RWB Ultra-Premium Handcrafted Vodka. We look forward to working with Curtis and with Bayou Music Center on many more events in the future.”

Named the 2014 Country Male Artist of the Year by the International Music and Entertainment Association, Curtis Braly has already introduced fans across the U.S. to RWB Vodka by touring the nation’s top country music markets in his RWB-branded tour bus. Earlier this year, Braly represented RWB Vodka at country music’s most important event: the Academy of Country Music Awards at AT&T Stadium in Arlington, Texas.

Handcrafted, American-made RWB Ultra-Premium Handcrafted Vodka is made with the highest-quality, non-GMO Idaho potatoes and pure mountain spring water and then refined by a five-stage filtration system that produces a gluten-free high-class vodka without the high-class price. It is available online to U.S. consumers and at more than 60 retail locations and 250 clubs, bars and restaurants.

For more information on the Aristocrat Group Corp., visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

International Stem Cell Corp. is expanding its presence in the emerging field of regenerative medicine through the development of its novel stem cell-based therapies and biomedical products. In recent months, this progress has translated into record-setting financial results, as the company has continued to position itself as a major player in the biotechnology industry.

“Stable increase in revenues from our biomedical businesses, ability to generate net income as a parent company and progress in demonstrating the safety and efficacy of our stem cells for the treatment of Parkinson’s disease and stroke position us as a leader in [the] regenerative medicine field,” Dr. Andrey Semechkin, chief executive officer and co-chairman of ISCO, stated in a news release.

In the second quarter of 2015, ISCO realized a 14 percent year-over-year increase in total revenue, recording $1.82 million. This growth was primarily fueled by the performance of the company’s subsidiary, Lifeline Skin Care, which recorded an 18 percent year-over-year increase in revenue for the period. In addition to expanding upon the customer base of its existing product lines, ISCO also completed the development and testing of two new products to be sold under the trusted Lifeline Skin Care brand moving forward. Lifeline Cell Technology, ISCO’s human cell manufacturing subsidiary, posted similar financial growth for the quarter, recording an 11 percent year-over-year increase in sales.

The company’s strong financial performance through its subsidiaries helped fund its considerable progress toward the development of its proprietary human parthenogenetic neural stem cells (hpNSCs). In preclinical testing, ISCO demonstrated the capability of its cells to significantly reduce neurological dysfunction following a stroke in animal models. Following the publication of two proof of concept studies that demonstrate the safety and efficacy of the company’s stem cell treatment techniques in both non-human primate and rodent animal models, ISCO expects to begin its Parkinson’s disease trials in the Australian market before the end of this year.

“We look forward to receiving Australian TGA authorization to start clinical trials,” continued Semechkin. “We expect to dose the first Parkinson’s disease patients in this trial in Q4 2015.”

For prospective shareholders, ISCO’s ability to generate revenue and maintain a strong cash position during clinical development programs is a promising indication of the company’s long-term viability. Look for ISCO to continue leaning on the established market presence of its subsidiaries in order to fund the ongoing clinical development of its promising Parkinson’s disease treatment program while simultaneously promoting sustainable returns.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

WRIT Media Group, through wholly-owned subsidiary Front Row Networks (FRN), is focused on delivering all of the fun and excitement of live shows at a fraction of the price by producing, acquiring and distributing live concert footage for worldwide digital broadcast in digitally-enabled movie theaters. Following their initial theatrical runs, the company plans to license the distribution rights to its concerts to DVD and Blu-Ray retailers – as well as free TV broadcasters, cable channels and mobile streaming providers – exponentially expanding the potential audience of individual shows. In addition to collecting licensing fees, WRIT also intends to sell merchandise and related products tailored to the showcased artist at theaters in which its concerts are exhibited, providing a supplementary revenue stream from the innovative entertainment model.

In an effort to capitalize on increased demand for exclusive programming, WRIT secures and distributes non-concert theatrical programming via mobile and internet platforms. Following this strategy, the company may acquire the rights to completed projects, finance production of entertainment programs or acquire businesses that own or control marketable content catalogues, as necessary to expand its exclusive library of content.

Moving forward, WRIT will look to expand upon and license its current library of more than 1,000 hours of edited concert footage in an effort to increase the marketability of FRN’s unique entertainment model. Leaning on the extensive expertise of the company’s management team, including well over a century of combined industry experience, WRIT is in a position to expand its presence in the growing concert and event promotion market, which accounted for approximately $25 billion in revenue during 2015, according to a report by IBISWorld.

For more information about the company, visit www.writmediagroup.com

Let us hear your thoughts: WRIT Media Group, Inc. Message Board